3v50

From Proteopedia

proteopedia linkproteopedia link

Revision as of 08:15, 29 February 2012 (edit) OCA (Talk | contribs) ← Previous diff		Revision as of 05:21, 8 August 2012 (edit) (undo) OCA (Talk | contribs) Next diff →
Line 1:		Line 1:
-	'''Unreleased structure'''	+	[[Image:3v50.jpg|left|200px]]
-	The entry 3v50 is ON HOLD until Paper Publication	+	{{STRUCTURE_3v50| PDB=3v50 | SCENE= }}
-	Authors: Wei, K., van den Akker, F.	+	===Complex of SHV S130G mutant beta-lactamase complexed to SA2-13===
-	Description: Complex of SHV S130G mutant beta-lactamase complexed to SA2-13	+	{{ABSTRACT_PUBMED_22438274}}
		+
		+	==About this Structure==
		+	[[3v50]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Klebsiella_pneumoniae Klebsiella pneumoniae]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3V50 OCA].
		+
		+	==Reference==
		+	<ref group="xtra">PMID:022438274</ref><references group="xtra"/>
		+	[[Category: Beta-lactamase]]
		+	[[Category: Klebsiella pneumoniae]]
		+	[[Category: Akker, F van den.]]
		+	[[Category: Wei, K.]]
		+	[[Category: Class a beta-lactamase fold]]
		+	[[Category: Hydrolase-hydrolase inhibitor complex]]
		+	[[Category: Hydrolyze b-lactam antibiotic]]

---

Revision as of 05:21, 8 August 2012

Template:STRUCTURE 3v50

Complex of SHV S130G mutant beta-lactamase complexed to SA2-13

Template:ABSTRACT PUBMED 22438274

About this Structure

3v50 is a 1 chain structure with sequence from Klebsiella pneumoniae. Full crystallographic information is available from OCA.

Reference

• Ke W, Rodkey EA, Sampson JM, Skalweit MJ, Sheri A, Pagadala SR, Nottingham MD, Buynak JD, Bonomo RA, van den Akker F. The importance of the trans-enamine intermediate as a beta-lactamase inhibition strategy probed in inhibitor-resistant SHV beta-lactamase variants. ChemMedChem. 2012 Jun;7(6):1002-8. doi: 10.1002/cmdc.201200006. Epub 2012 Mar 21. PMID:22438274 doi:10.1002/cmdc.201200006